What does ADGC mean in DISEASES


ADGC stands for Alzheimer Disease Genetics Consortium. It is a large-scale international research consortium dedicated to identifying the genetic basis of Alzheimer's disease (AD). ADGC was founded in 1995 and has since grown to include over 1,000 scientists from more than 50 countries.

ADGC

ADGC meaning in Diseases in Medical

ADGC mostly used in an acronym Diseases in Category Medical that means Alzheimer Disease Genetics Consortium

Shorthand: ADGC,
Full Form: Alzheimer Disease Genetics Consortium

For more information of "Alzheimer Disease Genetics Consortium", see the section below.

» Medical » Diseases

Mission

ADGC's mission is to identify the genetic variants that contribute to the development of AD. The consortium uses a variety of approaches to achieve this goal, including:

  • Conducting genome-wide association studies (GWAS)
  • Sequencing the genomes of AD patients and their families
  • Studying the genetic basis of AD in different populations

Accomplishments

ADGC has made significant contributions to the understanding of AD genetics. The consortium has identified several genetic variants that are associated with an increased risk of developing AD. These variants include:

  • APOE-ε4 allele: The APOE-ε4 allele is the strongest genetic risk factor for AD. People who carry one copy of the APOE-ε4 allele have a three- to four-fold increased risk of developing AD. People who carry two copies of the APOE-ε4 allele have a 12- to 15-fold increased risk.
  • TREM2 gene: Mutations in the TREM2 gene have been linked to an increased risk of developing AD. TREM2 is a gene that encodes a protein that is involved in the immune response. Mutations in the TREM2 gene can lead to a decreased ability of the immune system to clear amyloid-beta plaques from the brain. Amyloid-beta plaques are a hallmark of AD.
  • PLCG2 gene: Mutations in the PLCG2 gene have been linked to an increased risk of developing AD. PLCG2 is a gene that encodes a protein that is involved in the signaling pathway that leads to the production of amyloid-beta plaques. Mutations in the PLCG2 gene can lead to an increased production of amyloid-beta plaques.

Essential Questions and Answers on Alzheimer Disease Genetics Consortium in "MEDICAL»DISEASES"

What is the Alzheimer Disease Genetics Consortium (ADGC)?

The Alzheimer Disease Genetics Consortium (ADGC) is an international collaboration of researchers dedicated to identifying genetic factors that contribute to Alzheimer's disease. Founded in 2005, the ADGC has played a significant role in advancing our understanding of the genetic basis of Alzheimer's disease.

What are the goals of the ADGC?

The primary goal of the ADGC is to identify and characterize genetic variants that influence the risk of developing Alzheimer's disease. By studying large cohorts of individuals with and without Alzheimer's disease, the ADGC aims to identify common and rare genetic variants associated with the disease.

How does the ADGC conduct its research?

The ADGC collaborates with researchers from around the world to collect genetic data from individuals with and without Alzheimer's disease. This data is used to conduct genome-wide association studies (GWAS), which analyze millions of genetic variants to identify those that are associated with the disease.

What have been the major findings of the ADGC?

The ADGC has made significant contributions to our understanding of the genetic basis of Alzheimer's disease. The consortium has identified over 40 common genetic variants that are associated with an increased risk of developing the disease. These findings have provided valuable insights into the biological pathways involved in Alzheimer's disease and have helped to identify potential targets for drug development.

How can I participate in ADGC research?

Participation in ADGC research typically involves providing a blood sample or saliva sample for genetic analysis. Individuals can participate in research studies conducted by ADGC member institutions or through the ADGC's GeneMatch platform.

What is the impact of ADGC research on Alzheimer's disease treatment and prevention?

The findings of the ADGC have helped to refine our understanding of the genetic basis of Alzheimer's disease and have provided new insights into the biological mechanisms involved in the disease. This knowledge has the potential to lead to the development of more effective treatments and preventive measures for Alzheimer's disease.

Final Words: ADGC is a leading research consortium in the field of AD genetics. The consortium has made significant contributions to the understanding of the genetic basis of AD and has identified several genetic variants that are associated with an increased risk of developing the disease. ADGC's research is helping to pave the way for the development of new treatments and prevention strategies for AD.

Citation

Use the citation below to add this abbreviation to your bibliography:

Style: MLA Chicago APA

  • "ADGC" www.englishdbs.com. 22 Nov, 2024. <https://www.englishdbs.com/abbreviation/1191187>.
  • www.englishdbs.com. "ADGC" Accessed 22 Nov, 2024. https://www.englishdbs.com/abbreviation/1191187.
  • "ADGC" (n.d.). www.englishdbs.com. Retrieved 22 Nov, 2024, from https://www.englishdbs.com/abbreviation/1191187.
  • New

    Latest abbreviations

    »
    P
    PUSPITUR International Journal of Academic Research
    I
    Identification Situation Background Assessment Recomendation
    B
    Burnturk and Kettlehill Community Trust
    C
    Challenges and Prospects of CHIP
    G
    Generally Accepted Accounting Principles